Provention Bio (PRVB) Gains 26% Last Week.

We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm...

FDA Approves Most Expensive Drug Ever, @ $3.5 Million-Per-Dose, from uniQure (QURE).

Important to note, the FDA didn't approve the price, they approved the drug. It was priced afterwards. Second item it is a...

FDA Approval for Provention Bio (PRVB).

Re-cork the Champagne! We were contemplating (dreaming) about an opening price over $12, and then a drift up...

Adding Ardelyx (ARDX) $1.57 to Watch List.

FDA Advisory Committee Says Go Forth Young Man! While we hadn't previously owned Ardelyx, nor are they a...

Provention Biosciences (PRVB) Enters the Danger Zone.

Chart Looks Beautiful - But Nervous is why, we use soft and dry. LIVE QUOTE We'll...

Progressive Care (RXMD) Conference Call.

Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022 MIAMI, FL, Nov. 08, 2022...

VERU (VERU) $6.66, Goes Poof.

Veru Provides Update on FDA Advisory Committee Meeting Market Cap Plunges from...

Progressive Care Launches Native Remote Patient Monitoring Mobile App .

Progressive Care Launches Native Remote Patient Monitoring Mobile App and Physician Portal to Remotely Manage Chronic and Transitional Care

MedAvail Announces Technology Partnership with Progressive Care, Inc (RXMD).

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-based retail pharmacy company, and Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care”) a personalized healthcare...

Cosmos Health (COSM) and Smart for Life (SMFL) Execute Letter of Intent for Strategic...

LOI Calls for the Provision of SMFL Pan-European Access and COSM North American Access for Products and Services MIAMI...

Latest article

Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.

After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process. ...

Adding Silo Pharma (SILO) $3.50 to Watch List.

Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided...

Alzheimer Drug Trials

A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022 Eli...